Pierre Paul Riquet Hospital
Toulouse, Occitanie, 31300, France
NCT Number: NCT03950024
Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.
Looking for future studies?
Notify Me20 year–30 year
Male
Interventional
Not applicable
Toulouse, Occitanie, 31300, France
AMI leads to quadriceps atrophy, persistent knee pain, dynamic instability, and a higher rate of osteoarthritis. A recent literature review suggests that the AMI phenomenon is multifactorial, but not widely known and poorly understood. Known mechanisms include impaired motor function at rest, impaired transmission of information from joint sensory receptors, impaired excitability of the spinal reflex and impaired cortical activity. Several studies have suggested a link between ACL rupture and central nervous system reorganization. Among the neurophysiological investigations explored are the evoked somesthesic potentials, electroencephalography, and transcranial magnetic stimulation (TMS). However, these mechanisms alone do not explain the phenomenon in its entirety, suggesting that there are other mechanisms. Furthermore, no study has used functional brain MRI to assess the existence of similar changes in AMI.
This study plans to compare two groups of patients with an ACL rupture: a group with AMI, and a group without AMI. Both groups will undergo a functional brain MRI in order to analyse any modification of the sensory-motor network connectivity that could occur.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The functional brain MRI realized will be a examination with a resting sequence and a sequence during a movement imagination task. (knee bent)
Time frame: Day 0
A matrix of correlation coefficients, measured by MRI, representing the strength of the sensory-motor network connectivity at rest for each group.
Time frame: Day 0
An activation map of the motor representations of knee movement are measured by MRI
University Hospital, Toulouse
Other
Contribution of Functional Brain MRI to the Understanding of Arthrogenic Muscle Inhibition (AMI) in the Aftermath of Knee Trauma.
Acronym: CAMIK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06769711
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Trabzon, Turkey (Türkiye)
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07564336
Anterior Cruciate Ligament Graft Failure, Anterior Cruciate Ligament Injuries
Graz, Styria, Austria
View Trial DetailsNCT05440890
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Málaga, Spain
View Trial Details